Cofoe Medical Technology

Cofoe Medical Technology (Ticker: 1187 HK) manufactures and distributes home care medical devices through an integrated research, development, manufacturing, and distribution model. Its portfolio includes more than 200 product categories and over 10,000 stock-keeping units. The Chinese mainland is its primary geographic market, with sales also extending to Hong Kong, the United States, and the United Kingdom. In 2024, it ranked second among home care medical device providers in China by domestic revenue, with a reported 2.1% market share.

The scheduled listing date on Hong Kong Stock Exchange was May 6, 2026. The proposed offering comprises 27,000,000 shares at an indicative price of HKD 39.33 per share. The base offering would represent HKD 1.06 billion, approximately $135.31 million in gross proceeds, excluding any unexercised over-allotment.

BNP Paribas Securities Asia, Futu Securities International, and Huatai Financial Holdings are joint managers.